Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty-A study from a tertiary care center in South India

被引:14
作者
Valappil, Sanjai Pattu [1 ]
Kunjukrishnapillai, Sivaprasad [2 ]
Iype, Mathew [1 ]
Koshy, Alummoottil George [1 ]
Viswanathan, Sunitha [1 ]
Gupta, Prabha Nini [1 ]
Velayudhan, Radhakrishnan Vellikatu [1 ]
Ali, Faeez Mohamad [1 ]
机构
[1] Govt Med Coll, Dept Cardiol, Thiruvananthapuram 695011, Kerala, India
[2] TD Med Coll, Dept Cardiol, Alappuzha 688005, Kerala, India
关键词
Contrast; Nephropathy; anaemia; Angioplasty; Diuretic;
D O I
10.1016/j.ihj.2017.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study the incidence and predictors of Contrast induced nephropathy (CIN) in high risk patients undergoing coronary angioplasty. To study the applicability of the Mehran Risk Score (MRS) in the prediction of CIN in our population. Methods: This was a prospective observational study where patients with an estimated glomerular filtration rate (eGFR) between 30 and 60 ml/mt undergoing elective percutaneous coronary intervention (PCI) over a period of 15 months were evaluated prospectively for the development of CIN. The patients who developed CIN were then analysed for the presence of specific risk factors. The patients were categorized into the 4 risk groups based on the MRS. Results: 100 high risk patients underwent PCI during the study period. The incidence of CIN was 29%. On multivariate analysis, the presence of anemia (p = 0.007), increased contrast volume usage (as defined by >5* B.Wt/S.cr) (p = 0.012) and usage of loop diuretics (p = 0.033) were independently found to confer a significant risk of CIN. In patients belonging to the high Mehran risk group (MRS10- 15) and very high risk group (MRS >15) the risk of CIN was 3 fold (OR: 3.055, 95% CI: 1.18-7.94, p = 0.022) and 24 fold (OR: 24, 95% CI: 2.53-228.28, p = 0.006) higher respectively when compared to intermediate and low risk patients (MRS <10). Conclusion: The incidence of CIN in high risk patients undergoing PCI is substantially higher in our population compared to similar studies in the west. The MRS risk prediction is pertinent even in an Indian population. (C) 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.
引用
收藏
页码:399 / 404
页数:6
相关论文
共 28 条
[1]   Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994) [J].
Astor, BC ;
Muntner, P ;
Levin, A ;
Eustace, JA ;
Coresh, J .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) :1401-1408
[2]   Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention [J].
Barbieri, Lucia ;
Verdoia, Monica ;
Marino, Paolo ;
Suryapranata, Harry ;
De Luca, Giuseppe .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (09) :931-937
[3]   Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: Implications of varying definitions of contrast-induced nephropathy [J].
Capodanno, Davide ;
Ministeri, Margherita ;
Cumbo, Silvia ;
Dalessandro, Veronica ;
Tamburino, Corrado .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (06) :907-912
[4]   DOSING OF CONTRAST MATERIAL TO PREVENT CONTRAST NEPHROPATHY IN PATIENTS WITH RENAL-DISEASE [J].
CIGARROA, RG ;
LANGE, RA ;
WILLIAMS, RH ;
HILLIS, LD .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (06) :649-652
[5]   N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: Comprehensive meta-analysis [J].
Duong, MH ;
MacKenzie, TA ;
Malenka, DJ .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 64 (04) :471-479
[6]  
Evola Salvatore, 2012, Indian Heart J, V64, P484, DOI 10.1016/j.ihj.2012.07.007
[7]   Contrast-induced nephropathy [J].
Gleeson, TG ;
Bulugahapitiya, S .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (06) :1673-1689
[8]   Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies [J].
Goldenberg, I ;
Matetzky, S .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (11) :1461-1471
[9]   Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions [J].
Gurm, Hitinder S. ;
Dixon, Simon R. ;
Smith, Dean E. ;
Share, David ;
LaLonde, Thomas ;
Greenbaum, Adam ;
Moscucci, Mauro .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (09) :907-914
[10]   Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography - The RECOVER study: A randomized controlled trial [J].
Jo, Sang-Ho ;
Youn, Tae-Jin ;
Koo, Bon-Kwon ;
Park, Jim-Shik ;
Kang, Hyun-Jae ;
Cho, Young-Seok ;
Chung, Woo-Young ;
Joo, Gwon-Wook ;
Chae, In-Ho ;
Choi, Dong-Ju ;
Oh, Byung-Hee ;
Lee, Myoung-Mook ;
Park, Young-Bae ;
Kim, Hyo-Soo .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) :924-930